Plasticell company

Plasticell is a privately held biotechnology company using novel cell culture and drug discovery platforms to produce regenerative small molecule drugs.
Plasticell aims to develop drugs by elucidating the biochemical mechanisms that control the proliferation and differentiation of stem cells, the master cells responsible for tissue development and repair.
Technology: Regenerative Medicine
Industry: Regenerative Medicine
Headquarters: London, England, United Kingdom
Founded Date: 6-24
Employees Number: 11-50
Funding Status: N/A
Investors Number: 1
Total Funding: £4.2M
Estimated Revenue: $1M to $10M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership